None listed
Conditions
Interventions
Subjects will be infused with L-N monomethyl arginine (LNMMA) and saline (placebo) in a single blinded randomized design on two separate days to assess the effect of nitric oxide synthase inhibition on arterial stiffness. Initially there will be a 10 minute baseline period. Then the LNMMA or saline will be infused over 5 minutes, after which there will be another 5 minute baseline period. Following this there will be the 20 minute period of hypoxia and then a 10 minute recovery period. During this the subjects will breathe through a mouthpiece connected to special equipment which delivers different gas mixtures and enables the delivery of the hypoxic exposure. Heart rate blood pressure, arterial stiffness ( via pulse wave analysis), and peripheral vasoconstriction (via peripheral arterial tonometry PAT) will be measured.
Sponsors
Study design
Eligibility
Inclusion criteria
Healthy men
Exclusion criteria
History of obstructive sleep apnoea or cardiovascular or respiratory disease, Smoker, Treatment with cardiovascular or respiratory medication.